Financial Year |
March 31 2023 |
Monetary Funds |
204,519,569.35 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
472,344,502.95 |
Advances to Suppliers |
86,054,344.12 |
Other Receivables |
63,721,780.25 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
343,898,717.88 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
5,726,540.81 |
Total Current Assets |
1,187,031,342.51 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
33,201,382.31 |
Investment Properties |
-- |
Fixed Assetes |
727,968,145.66 |
Under-construction Projects |
62,536,741.87 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
125,324,962.94 |
R&D expenses |
-- |
Goodwill |
184,021,493.60 |
Long-Term Deferred and Prepaid Expenses |
30,269,445.21 |
Deferred Income Tax Assets |
48,763,594.09 |
Other Non-Current Assets |
12,966,049.50 |
Sub-Total of Non-Current Assets |
1,383,288,080.12 |
Total Assets |
2,570,319,422.63 |
Short-Term Loans |
17,410,175.00 |
Trading Financial liabilities |
-- |
Notes Payable |
360,244,173.76 |
Accounts Payable |
216,941,204.51 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
30,066,151.92 |
Taxes Payable |
12,448,062.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
29,417,150.36 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
76,150,898.65 |
Other Current Liabilities |
17,083,615.77 |
Sub-Total of Current Liabilities |
1,037,890,299.46 |
Long-term Loans |
4,800,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
102,416,650.97 |
Total Liabilities |
1,140,306,950.43 |
Paid-In Capital(Or Share Stock) |
537,586,717.00 |
Capital Surplus |
607,416,526.27 |
Surplus Reserve |
63,777,707.37 |
LESS:Treasury Stock |
24,681,857.90 |
Undistributed Profits |
244,698,467.27 |
Minority Stockholder's Interest |
1,214,912.19 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,428,797,560.01 |
Owner's Equity(Stockholder's Equity) |
1,430,012,472.20 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,570,319,422.63 |